Hagop Youssoufian

2011 - ZIOPHARM Oncology

In 2011, Hagop Youssoufian earned a total compensation of $1.9M as President of Research and Development and Chief Medical Officer at ZIOPHARM Oncology.

Compensation breakdown

Bonus$47,250
Option Awards$1,050,000
Salary$207,981
Stock Awards$582,826
Other$9,469
Total$1,897,526

Youssoufian received $1.1M in option awards, accounting for 55% of the total pay in 2011.

Youssoufian also received $47.3K in bonus, $208K in salary, $582.8K in stock awards and $9.5K in other compensation.

Rankings

In 2011, Hagop Youssoufian's compensation ranked 3,473rd out of 10,747 executives tracked by ExecPay. In other words, Youssoufian earned more than 67.7% of executives.

ClassificationRankingPercentile
All
3,473
out of 10,747
68th
Division
Manufacturing
1,212
out of 3,960
69th
Major group
Chemicals And Allied Products
237
out of 1,033
77th
Industry group
Drugs
133
out of 781
83rd
Industry
Pharmaceutical Preparations
111
out of 571
81st
Source: SEC filing on April 30, 2014.

Youssoufian's colleagues

We found three more compensation records of executives who worked with Hagop Youssoufian at ZIOPHARM Oncology in 2011.

2011

Jonathan Lewis

ZIOPHARM Oncology

Chief Executive Officer

2011

Caesar Belbel

ZIOPHARM Oncology

Chief Legal Officer

2011

Richard Bagley

ZIOPHARM Oncology

Chief Financial Officer

In-depth

You may also like